Close Menu

NEW YORK (GenomeWeb) – Healthcare private equity firm Shore Capital Partners announced on Tuesday that it has sold laboratory diagnostics service provider ClearPath Diagnostics to Laboratory Corporation of America.

The deal closed on Monday. Further details of the acquisition were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Three genetic testing companies form a coalition to influence how Congress considers genetic privacy, The Hill reports.

University of California, San Diego researchers investigate how skin care products influence the skin microbiome, Scientific American reports.

The Wall Street Journal examines billing codes used by uBiome.

In PNAS this week: links between lung adenocarcinoma and lncRNA, algorithm to impute and cluster Hi-C interaction profiles from single cells, and more.